podophyllotoxin has been researched along with Small Cell Lung Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buschmann, MD; Gal, S; Jean, M; Li, Z; Liao, S; Merzouki, A; Slilaty, SN; Young, RS | 1 |
1 other study(ies) available for podophyllotoxin and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Adva-27a, a novel podophyllotoxin derivative found to be effective against multidrug resistant human cancer cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Fluorine Compounds; Glycosides; Humans; Male; Microsomes, Liver; Monosaccharides; Podophyllotoxin; Rats; Rats, Sprague-Dawley; Small Cell Lung Carcinoma; Topoisomerase II Inhibitors | 2012 |